相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and-3
R. B. Warren et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi et al.
LANCET (2021)
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis
Richard B. Warren et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Philip J. Mease et al.
LANCET (2020)
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
Jean-Philippe Lacour et al.
DERMATOLOGY AND THERAPY (2020)
Detection of subclinical skin manifestation in patients with psoriasis and psoriatic arthritis by fluorescence optical imaging
A. Schmidt et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Lyn D. Ferguson et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Psoriatic arthritis - new perspectives
Przemyslaw Krakowski et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
Jillian Frieder et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2018)
A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey
C. E. M. Griffiths et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Quality of life in psoriatic arthritis
Tania Gudu et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs
Angela McArdle et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Current concepts and unmet needs in psoriatic arthritis
Farrouq Mahmood et al.
CLINICAL RHEUMATOLOGY (2018)
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis
April W. Armstrong et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies
Siba P. Raychaudhuri et al.
JOURNAL OF AUTOIMMUNITY (2017)
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence
Luisa Costa et al.
DRUGS IN R&D (2017)
Ixekizumab: A Review in Moderate to Severe Plaque Psoriasis
Yahiya Y. Syed
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice
Steven R. Feldman et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
Laura C. Coates et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
M. Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
Muhammad Haroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis
Hema N. Viswanathan et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper
G. Girolomoni et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
Chris B. Russell et al.
JOURNAL OF IMMUNOLOGY (2014)
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting
Junko Takeshita et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity
Donald M. Bushnell et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2013)
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J. Mease et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Conversations on psoriasis - what patients want and what physicians can provide: A qualitative look at patient and physician expectations
Elizabeth E. Uhlenhake et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2010)
Psoriasis and systemic inflammation: underdiagnosed enthesopathy
G. Girolomoni et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis
Dennis A. Revicki et al.
DERMATOLOGY (2008)
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
DD Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
分享论文
